Terms: = Ovarian cancer AND MET, RCCP2, 4233, ENSG00000105976, P08581, HGFR, AUTS9
1266 results:
1. Racial and Ethnic Disparities in the Incidence of Anti-NMDA Receptor Encephalitis.
Alsalek S; Schwarzmann KB; Budhathoki S; Hernandez-Lopez V; Smith JB; Li BH; Langer-Gould A
Neurol Neuroimmunol Neuroinflamm; 2024 Jul; 11(4):e200255. PubMed ID: 38728608
[TBL] [Abstract] [Full Text] [Related]
2. Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses.
Friedman CF; Manning-Geist BL; Zhou Q; Soumerai T; Holland A; Da Cruz Paula A; Green H; Ozsoy MA; Iasonos A; Hollmann T; Leitao MM; Mueller JJ; Makker V; Tew WP; O'Cearbhaill RE; Liu YL; Rubinstein MM; Troso-Sandoval T; Lichtman SM; Schram A; Kyi C; Grisham RN; Causa Andrieu P; Wherry EJ; Aghajanian C; Weigelt B; Hensley ML; Zamarin D
Nat Med; 2024 May; 30(5):1330-1338. PubMed ID: 38653864
[TBL] [Abstract] [Full Text] [Related]
3. FETPY: a Diiron(I) Thio-Carbyne Complex with Prominent Anticancer Activity In Vitro and In Vivo.
Mihajlović E; Biancalana L; Jelača S; Chiaverini L; Dojčinović B; Dunđerović D; Zacchini S; Mijatović S; Maksimović-Ivanić D; Marchetti F
J Med Chem; 2024 May; 67(9):7553-7568. PubMed ID: 38639401
[No Abstract] [Full Text] [Related]
4. Randomized Phase II Study of Gemcitabine With or Without ATR Inhibitor Berzosertib in Platinum-Resistant ovarian cancer: Final Overall Survival and Biomarker Analyses.
Konstantinopoulos PA; Cheng SC; Lee EK; da Costa AABA; Gulhan D; Wahner Hendrickson AE; Kochupurakkal B; Kolin DL; Kohn EC; Liu JF; Penson RT; Stover EH; Curtis J; Sawyer H; Polak M; Chowdhury D; D'Andrea AD; Färkkilä A; Shapiro GI; Matulonis UA
JCO Precis Oncol; 2024 Apr; 8():e2300635. PubMed ID: 38635934
[TBL] [Abstract] [Full Text] [Related]
5. Systematic review of the molecular basis of hereditary breast and ovarian cancer syndrome in Brazil: the current scenario.
de Freitas Ribeiro AA; Junior NMC; Dos Santos LL
Eur J Med Res; 2024 Mar; 29(1):187. PubMed ID: 38504328
[TBL] [Abstract] [Full Text] [Related]
6. Tropomyosin1 isoforms underlie epithelial to mesenchymal plasticity, metastatic dissemination, and resistance to chemotherapy in high-grade serous ovarian cancer.
Xu T; Verhagen MP; Teeuwssen M; Sun W; Joosten R; Sacchetti A; Ewing-Graham PC; Jansen MPHM; Boere IA; Bryce NS; Zeng J; Treutlein HR; Hook J; Hardeman EC; Gunning PW; Fodde R
Cell Death Differ; 2024 Mar; 31(3):360-377. PubMed ID: 38365970
[TBL] [Abstract] [Full Text] [Related]
7. A systematic review of association between use of hair products and benign and malignant gynecological conditions.
Farooq H; Mhatre P; Aggarwal R; Robinson MT; Joseph E; Segars J; Singh B
Eur J Obstet Gynecol Reprod Biol; 2024 Apr; 295():160-171. PubMed ID: 38364603
[TBL] [Abstract] [Full Text] [Related]
8. Causal relationship between gut microbiota and polycystic ovary syndrome: a literature review and Mendelian randomization study.
Sun J; Wang M; Kan Z
Front Endocrinol (Lausanne); 2024; 15():1280983. PubMed ID: 38362275
[TBL] [Abstract] [Full Text] [Related]
9. Neuroendocrine neoplasms of the ovary: a review of 63 cases.
Flores Legarreta A; Saab R; Gonzales NR; Chisholm GB; Westin SN; Hillman RT; Frumovitz M
Int J Gynecol Cancer; 2024 Apr; 34(4):566-573. PubMed ID: 38290783
[TBL] [Abstract] [Full Text] [Related]
10. The impact of lymphadenectomy on ovarian clear cell carcinoma: a systematic review and meta-analysis.
Liu Y; Geng F; Zhang H; Xue J; Chu R
World J Surg Oncol; 2024 Jan; 22(1):37. PubMed ID: 38287354
[TBL] [Abstract] [Full Text] [Related]
11. Medulloblastoma and other neoplasms in patients with heterozygous germline SUFU variants: A scoping review.
Lee SG; Evans G; Stephen M; Goren R; Bondy M; Goodman S
Am J Med Genet A; 2024 Jun; 194(6):e63496. PubMed ID: 38282294
[TBL] [Abstract] [Full Text] [Related]
12. Regionalizing ovarian cancer cytoreduction to high-volume centers and the impact on patient travel in New York State.
Kahn RM; Ma X; Gordhandas S; Yeoshoua E; Ellis RJ; Zhang X; Aviki EM; Abu-Rustum NR; Gardner GJ; Sonoda Y; Zivanovic O; Long Roche K; Jewell E; Boerner T; Chi DS
Gynecol Oncol; 2024 Mar; 182():141-147. PubMed ID: 38262237
[TBL] [Abstract] [Full Text] [Related]
13. Reduced healthcare access contributes to delay of care in endometrial cancer.
Fife AJ; Najor AJ; Aspir TB; Haines KE; Vilardo NA; Isani SS; Cowan M; Gressel GM; Ye KQ; Nevadunsky NS; Kuo DY; Lin KY
Gynecol Oncol; 2024 Mar; 182():115-120. PubMed ID: 38262233
[TBL] [Abstract] [Full Text] [Related]
14. EGFR, HLA-G, CD70, c-met, and NY-ESO1 as potential biomarkers in high grade epithelial ovarian carcinoma.
Vo D; Liu Y; Sood AK; Rezvani K; Jazaeri AA; Liu J
Cancer Biomark; 2024; 39(4):289-298. PubMed ID: 38250760
[TBL] [Abstract] [Full Text] [Related]
15. Serial cytoreductive surgery and survival outcomes in recurrent adult-type ovarian granulosa cell tumors.
How JA; Legarreta AF; Handley KF; Fellman B; Foster KI; Glassman D; Vuttaradhi VK; Brodsky AL; Lawson B; Frumovitz M; Westin SN; Ramondetta LM; Gershenson DM; Sood AK; Hillman RT
Am J Obstet Gynecol; 2024 May; 230(5):544.e1-544.e13. PubMed ID: 38191019
[TBL] [Abstract] [Full Text] [Related]
16. Loss of LECT2 promotes ovarian cancer progression by inducing cancer invasiveness and facilitating an immunosuppressive environment.
Wu CJ; Pan KF; Chen JQ; Tao Y-; Liu YC; Chen BR; Hsu C; Wang MY; Sheu BC; Hsiao M; Hua KT; Wei LH
Oncogene; 2024 Feb; 43(7):511-523. PubMed ID: 38177412
[TBL] [Abstract] [Full Text] [Related]
17. NRG-GY012: Randomized phase 2 study comparing olaparib, cediranib, and the combination of cediranib/olaparib in women with recurrent, persistent, or metastatic endometrial cancer.
Rimel BJ; Enserro D; Bender DP; Jackson CG; Tan A; Alluri N; Borowsky M; Moroney J; Hendrickson AW; Backes F; Swisher E; Powell M; MacKay H
Cancer; 2024 Apr; 130(8):1234-1245. PubMed ID: 38127487
[TBL] [Abstract] [Full Text] [Related]
18. Impact of ovary-sparing treatment planning on plan quality, treatment time and gamma passing rates in intensity-modulated radiotherapy for stage I/II cervical cancer.
Huang Y; Qin T; Yang M; Liu Z
Medicine (Baltimore); 2023 Dec; 102(50):e36373. PubMed ID: 38115303
[TBL] [Abstract] [Full Text] [Related]
19. Previous external beam radiation therapy for pelvic malignancy increases complications of total hip arthroplasty.
Pondugula P; Spiering T; Parel PM; Agarwal AR; Bahoravitch TJ; Golladay GJ
Hip Int; 2024 May; 34(3):311-319. PubMed ID: 38087843
[TBL] [Abstract] [Full Text] [Related]
20. Inherited BRCA1 and RNF43 pathogenic variants in a familial colorectal cancer type X family.
Chan JM; Clendenning M; Joseland S; Georgeson P; Mahmood K; Joo JE; Walker R; Como J; Preston S; Chai SM; Chu YL; Meyers AL; Pope BJ; Duggan D; Fink JL; Macrae FA; Rosty C; Winship IM; Jenkins MA; Buchanan DD
Fam Cancer; 2024 Mar; 23(1):9-21. PubMed ID: 38063999
[TBL] [Abstract] [Full Text] [Related]
[Next]
